IRCT20210130050179N8招募中2 期
Evaluating the safety and efficiency of the combined use of mask and hair spray with the iDR brand, a product of Vera Rahesh Pharmed Company in repairing and improving the appearance of damaged hair compared to placebo.
Vera Rahesh Pharmed Pharmaceutical Company0 个研究点目标入组 14 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- Female
入选标准
- •female aged 18-55 years.
- •Good general health
- •People with damaged hair naturally or after using hair color, including tangles, frizz, frizz, dullness.
- •Voluntary participation and sign the written informed consent.
排除标准
- •People with known allergies to mask or spray ingredients
- •Active acute or chronic scalp disease such as psoriasis, lichen planus, etc.
- •Having any type of malignancy
- •Scalp surgeries
- •Pregnancy and breastfeeding
- •Change in shampoo used or supplements taken such as zinc and vitamin C during the study.
- •Using 2 in 1 shampoo containing softener, hair ointment, hair gel or tuft during the study
研究者
相似试验
进行中（未招募）
不适用
Study on Tuberculosis resistant to treatmentCTRI/2019/01/017310ICMR National Institute for Research inTuberculosis
已完成
2 期
A Study of the Safety and Efficacy of the Combination of Gemcitabine and Docetaxel with MORAb-004 in Metastatic Soft Tissue Sarcomasoft tissue cancer10072990NL-OMON39691Morphotek, Inc10
进行中（未招募）
1 期
A clinical trial that is evaluating how safe and effective an experimental treatment called MORAb-004 is when used in combination with Gemcitabine and Docetaxel in patients diagnosed with Metastatic Soft Tissue Sarcoma.EUCTR2012-001399-12-NLMorphotek Inc.200
进行中（未招募）
1 期
A clinical trial that is evaluating how safe and effective an experimental treatment called MORAb-004 is when used in combination with Gemcitabine and Docetaxel in patients diagnosed with Metastatic Soft Tissue Sarcoma.Metastatic Soft Tissue SarcomaMedDRA version: 15.1Level: HLGTClassification code 10041299Term: Soft tissue sarcomasSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2012-001399-12-BEMorphotek Inc.200
已完成
不适用
Effect of the combination of artificial dura and umbilical cord and placenta mesenchymal stem cell-derived exosomes in patients with complete spinal cord injuryComplete spinal cord injury.Injury of spinal cord, level unspecifiedT09.3IRCT20200502047277N1Shahid Beheshti University of Medical Sciences60